FDA Approves Rituximab for Children with GPA & MPA
Iguratimod May Hold Promise for Treating Autoimmune Disease
FDA Approves Upadacitinib for RA
Filgotinib Promising for RA
FDA Approves AbbVie’s New Rheumatoid Arthritis Drug
Otilimab Begins Phase 3 Clinical Studies for RA
Baricitinib: Early vs. Late Treatment Outcomes in RA Patients
Secukinumab: The Real World Experience of PsA Patients
RA Patients May Safely Stop Methotrexate in Tofacitinib Combination Therapy
- 1
- 2
- 3
- …
- 17
- Next Page »